Clearance Summary
CARDIOLIPIN A EIA TEST SYSTEM received FDA 510(k) clearance under submission number K946216, sponsored by Hogan & Hartson. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1996-01-24.
- Submission: K946216
- Applicant / Sponsor: Hogan & Hartson
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5660
- Decision date: 1996-01-24
Classification & Regulation
This clearance is catalogued under FDA product code MID and 21 CFR 866.5660, within the Immunology review panel as a Class II device.